logo

For the Inventor, By the Inventor

Kumamoto, Japan

Juridical Foundation the Chemo-Sero-Therapeutic Research Institute


USPTO Granted Patents = 114



Forward Citations = 1,202

Loading Chart...
Loading Chart...

209 inventors (with patents filed for the assignee):

goldMedal Hiroaki Maeda (24 out of 57 patents)

silverMedal Chikateru Nozaki (17 out of 33 patents)

bronzeMedal Sachio Tokiyoshi (16 out of 16 patents)

4.  Hiroshi Mizokami (14 out of 15 patents)

5.  Toshihiro Nakashima (12 out of 20 patents)

6.  Kazuhiko Kimachi (10 out of 13 patents)

7.  Tomohiro Nakagaki (9 out of 9 patents)

8.  Fukusaburo Hamada (9 out of 13 patents)

9.  Kenji Soejima (8 out of 17 patents)

10.  Takayuki Imamura (8 out of 12 patents)

11.  Masashi Sakaguchi (8 out of 12 patents)

12.  Yasuyuki Eda (8 out of 9 patents)

13.  Nobuya Ohtomo (7 out of 9 patents)

14.  Tetsuo Kawahara (7 out of 7 patents)

15.  Kazuhisa Sugimura (6 out of 10 patents)


Core Competencies:
Disseminated Intravascular Coagulation
Hepatitis C Virus Inhibitors
Monoclonal Antibody Preparation
Recombinant Factor X
Von Willebrand Factor Cleaving Protease
Human Anti-Amyloid Beta Peptide Antibody
Peptide Cytotoxicity Inhibitory Activity
Live Smallpox Vaccine
Human Serum Albumin Preparation
Hemostatic Compositions
Medicinal Compositions for Thrombopathy
Recombinant Anti-Osteopontin Antibody

114 patents:

1. 8759018 - Method for determining treatment of disseminated intravascular coagulation (2014-06-24),
2. 8715655 - Human anti-α9 integrin antibody (2014-05-06),
3. 8466273 - Hepatitis C virus inhibitors (2013-06-18),
4. 8361749 - [object Object] (2013-01-29),
5. 8332159 - Method for enhancing efficacy of preparation of monoclonal antibody (2012-12-11),
6. 8293874 - Recombinant factor X with no glycosylation and method for preparing the same (2012-10-23),
7. 8283137 - Process for producing recombinant fibrinogen highly producing cell and highly producing cell (2012-10-09),
8. 8277820 - [object Object] (2012-10-02),
9. 8258264 - Process for producing albumin preparation (2012-09-04),
10. 8226958 - Modified SEB and prophylactics/remedies for immunopathy containing the same (2012-07-24),
11. 8222002 - Human anti-amyloid beta peptide antibody and fragment of said antibody (2012-07-17),
12. 8173777 - Recombinant Factor X with no glycosylation and method for preparing the same (2012-05-08),
13. 8106015 - Method for enhancing immune response with peptide (2012-01-31),
14. 8067221 - Von Willebrand factor (vWF)-cleaving protease (2011-11-29),
15. 8043629 - Bioabsorbable synthetic nonwoven fabric holding thrombin (2011-10-25),
The Juridical Foundation the Chemo-Sero-Therapeutic Research Institute (JCST) is a non-profit research organization based in Japan. Established in 1917, JCST is committed to advancing research and development in the fields of chemistry, serology, and therapeutics. With a focus on innovative medical technologies and pharmaceuticals, the institute plays a crucial role in the discovery of new treatments and vaccines to combat various diseases. JCST operates under government support and collaborates with academic institutions and industry partners to promote scientific advancements for the betterment of public health.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

114 Patents

#2 in Kumamoto

#1,012 in Japan

#6,748 in the World

...
Kumamoto, Japan

Juridical Foundation the Chemo-Sero-Therapeutic Research Institute

Forward Citations = 1,202

209 inventors:

goldMedal Hiroaki Maeda (24 out of 57 patents)

silverMedal Chikateru Nozaki (17 out of 33 patents)

bronzeMedal Sachio Tokiyoshi (16 out of 16 patents)

4.  Hiroshi Mizokami (14 out of 15 patents)

5.  Toshihiro Nakashima (12 out of 20 patents)

Please report any incorrect information to support@idiyas.com
Loading…